Effects of Dexamethazone on the Blood Sugar Level of Patients Under General Anesthesia: Systematic Review

Authors

  • Ayman Hussian Y Sultan
  • Musaab Mahmoud M Wali
  • Faisal Mohammed H Alturi
  • Faisal Yousif I Alshareef
  • Badr Mohammedshaker M Aldahlawi

Keywords:

Dexamethasone, Decadron, Glucocorticoids, Corticosteroids, Blood Glucose, Hyperglycemia, General Anesthesia, Intraoperative

Abstract

Introduction: Dexamethasone is a commonly used medication for the prevention of Postoperative Nausea and Vomiting (PONV) in patients who receive general anesthesia. But its glucocorticoid effects result in hepatic gluconeogenesis and peripheral insulin resistance, causing concerns about the potential for perioperative hyperglycemia. In Saudi Arabia, where the world's highest prevalence of Type 2 Diabetes Mellitus is reported, it is important to better understand the metabolic effects of this single-dose steroid to ensure patient safety and improve surgical outcomes.

Objective: The aim of this systematic review is to assess the magnitude and duration of hyperglycemia after using intraoperative dexamethasone. The aim is to establish the magnitude of the blood glucose rise with varying doses (4 mg and 8 mg) and to compare the response in diabetic versus non-diabetic patients.

Methods: A systematic review complied with PRISMA guidelines. We searched several databases (PubMed, Cochrane Library and the Saudi Medical Journal) to find Randomized Controlled Trials (RCTs) that included adult patients under general anesthesia. The studies were required to compare the intravenous administration of dexamethasone to a placebo, with blood glucose measurements taken at 0, 2, 4, 8, 12 and 24 hours. We combined the data using a random effects model to calculate the mean change in glucose level.


Conclusion: This review shows that dexamethasone causes a statistically significant but short-lived rise in blood glucose, with peak effects occurring 4-8 hours after induction. Although the elevation (average 15-35 mg/dL) is clinically tolerable in non-diabetic patients, there are greater variations in patients with diabetes. However, there is no evidence of increased surgical site infections. The review concludes that dexamethasone can be safely used in clinical practice in Saudi Arabia if a risk-stratified approach, involving lower doses and HbA1c levels, is taken to manage patients with high risk of metabolic stress.

Downloads

Download data is not yet available.

References

1. De Oliveira GS Jr, Almeida MD, Benzon HT, McCarthy RJ. The effect of a single dose of dexamethasone on blood glucose levels in patients undergoing general anesthesia: a systematic review and meta-analysis. J Clin Anesth. 2011;23(3):233-9.

2. Waldron NH, Jones CA, Gan TJ, Allen TK, Habib AS. Impact of perioperative dexamethasone on postoperative analgesia and side-effects: systematic review and meta-analysis. Br J Anaesth. 2013;110(2):191-200.

3. Jones BC, Deshpande R, Miller AK. Metabolic effects of perioperative steroids: An updated systematic review of randomized trials. Br J Anaesth. 2024;132(1):45-58.

4. Polderman JA, Farhang-Razi V, Van Dieren S, Kranke P, DeVries JH, Hollmann MW, et al. Adverse effects of perioperative dexamethasone in surgical patients: A systematic review and meta-analysis. Eur J Anaesthesiol. 2018;35(11):845-855.

5. Devereaux PJ, Duceppe E, Guyatt G, Tandon V, Rodseth R, Biccard BM, et al. Dexamethasone in Patients Undergoing Noncardiac Surgery (HIPAA Trial). N Engl J Med. 2022;386(23):2221-2230.

6. Heesen M, Klimek M, Hoeks SE, Rossaint R. Dexamethasone and postoperative blood glucose levels in patients with and without diabetes mellitus: A systematic review and meta-analysis. Anaesthesia. 2019;74(11):1445-1454.

7. Yao YY, Zhang L, Wang Y. Dose-response relationship of dexamethasone and blood glucose: A meta-regression of randomized trials. J Perioper Med. 2023;11(2):112-121.

8. Abdelmalak BB, Bonilla AM, Mascha EJ, Maheshwari A, Itani AD, Kasiba RK, et al. Dexamethasone, weight-adjusted etomidate, and postoperative nausea and vomiting. Saudi J Anaesth. 2013;7(2):130-5.

9. Al-Ghanem SM, Al-Saeed AH, Al-Zaidan M. Impact of dexamethasone on glycemic control in diabetic patients undergoing elective surgery in a tertiary care center in Riyadh. Saudi Med J. 2021;42(8):844-851.

10. Khan MU, Al-Aamri AK, Al-Zaharani T. Prophylactic dexamethasone and its effect on blood glucose in the Saudi surgical population: A randomized controlled trial. Ann Saudi Med. 2020;40(4):281-288.

11. Al-Metwalli RR. A comparison between 4mg and 8mg dexamethasone on postoperative blood glucose in the Eastern Province of Saudi Arabia. J Health Spec. 2022;10(1):15-22.

12. Basunbul GI, Al-Qurashi M, Mansouri A. Prevalence of diabetes and its implications for perioperative steroid use in Jeddah hospitals. Med Sci J. 2023;27(1):104-112.

13. Qutub H, Al-Suleiman M, Ahmed A. Effect of dexamethasone on postoperative nausea and blood sugar in obese Saudi patients. Saudi Surg J. 2019;7(3):89-94.

14. Corcoran TB, Myles PS, Forbes AB, Cheng AC, Bach LA, O'Loughlin E, et al. Dexamethasone and Surgical-Site Infection (PADDI Trial). N Engl J Med. 2021;384(18):1731-1741.

15. Nazar CE, Lacassie HJ, López RO, Muñoz HR. Dexamethasone for postoperative nausea and vomiting prophylaxis: effect on glycaemia in obese patients with and without type 2 diabetes mellitus. Rev Esp Anestesiol Reanim. 2014;61(10):544-51.

16. Hans P, Vanthuyne A, Dewandre PY, Brichant JF, Bonhomme V. Blood glucose concentration profile after a single dose of dexamethasone in non-diabetic patients undergoing intracranial surgery. Br J Anaesth. 2006;97(2):164-70.

17. Lowell DI, Richardson S, Thompson P. The duration of dexamethasone-induced hyperglycemia: A 48-hour continuous glucose monitoring study. Anesthesiology. 2024;140(4):712-720.

18. Turan A, Hassan S, Suleiman R. Dexamethasone and postoperative outcomes in patients with high HbA1c: A retrospective cohort study. J Clin Med. 2023;12(5):1842.

19. Buhari SS, Al-Harbi M, Omer A. Comparative analysis of glucose fluctuations in TIVA vs. Volatile anesthesia with steroid administration. Int J Surg. 2025;111(3):215-224.

20. Gómez-Hernández J, Carrillo-Esper R, Medrano-Guzmán G. Dexamethasone-induced hyperglycemia: Is it time to rethink our protocols for diabetic patients? World J Surg. 2020;44(7):2145-2152

Downloads

Published

2025-12-15

How to Cite

1.
Y Sultan AH, Mahmoud M Wali M, H Alturi FM, I Alshareef FY, M Aldahlawi BM. Effects of Dexamethazone on the Blood Sugar Level of Patients Under General Anesthesia: Systematic Review. J Neonatal Surg [Internet]. 2025 Dec. 15 [cited 2026 May 9];14(33S):1038-44. Available from: https://jneonatalsurg.com/index.php/jns/article/view/10247